Rosen Law Firm announces deadline for Tenax Therapeutics class action lawsuit
Investors who purchased Tenax Therapeutics securities between November 2023 and August 2026 have until December 28 to join a pending securities fraud lawsuit.
The Rosen Law Firm has issued a notice to investors who acquired Tenax Therapeutics, Inc. (NASDAQ: TENX) stock during the period spanning November 13, 2023, and August 7, 2026. The firm is seeking lead plaintiffs for a class action complaint alleging that the company failed to disclose material information regarding its business operations during this timeframe.
Legal proceedings center on allegations that the company made misleading statements to shareholders. The lawsuit contends that these omissions led to financial losses for investors when the actual state of the company's affairs was revealed to the market.
Interested parties must take action by December 28, 2026, to serve as a lead plaintiff in the litigation. Participation in the lawsuit does not carry upfront costs, as the law firm is operating on a contingency basis.